The Food and Drug Administration’s Office of Generic Drugs program funded approximately $20 million in generic drug science and research programs in 2021.
Generic drugmakers report making adjustments to their supply chains, including changes in transportation and sourcing strategies, as well as confidence in their outlook for the year ahead.
The new digital service aims to make it easy for eligible consumers to obtain at-home COVID-19 tests through their insurance with zero out-of-pocket costs.